AOD9604

AOD9604 is a modified peptide fragment of human growth hormone, comprising amino acids 176–191. It is studied for its selective action on lipolytic pathways without activating the IGF-1 receptor. AOD9604 is commonly used in vitro to explore mechanisms of fat metabolism, cell signaling, and metabolic regulation.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Not for human consumption

AOD9604 is a synthetic peptide derived from amino acids 176–191 of human growth hormone (HGH). This modified peptide fragment has been studied in laboratory and preclinical settings for its selective interaction with pathways associated with lipid metabolism and metabolic signaling. Unlike full-length growth hormone, AOD9604 has been investigated for its ability to influence lipolytic mechanisms without significant activation of the IGF-1 receptor pathway.

IGF-1 Receptor Selectivity

AOD9604 is commonly referenced in research due to observations that it may exert metabolic signaling effects without substantially stimulating the insulin-like growth factor-1 (IGF-1) receptor. This characteristic has made the peptide a subject of interest in studies examining selective metabolic pathway activation and peptide specificity.

Metabolic and Adipocyte Research

Experimental models have investigated AOD9604 in relation to adipocyte signaling and lipid metabolism. Studies often focus on how the peptide may influence pathways involved in fat storage, fat breakdown, and cellular metabolic balance within adipose tissue systems.